Year |
Citation |
Score |
2022 |
Zhou RW, Xu J, Martin TC, Zachem AL, He J, Ozturk S, Demircioglu D, Bansal A, Trotta AP, Giotti B, Gryder B, Shen Y, Wu X, Carcamo S, Bosch K, et al. A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma. Nature Communications. 13: 6041. PMID 36253360 DOI: 10.1038/s41467-022-33377-8 |
0.333 |
|
2020 |
Ozturk S, Mathur D, Zhou RW, Mulholland D, Parsons R. Leflunomide triggers synthetic lethality in PTEN-deficient prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 32661432 DOI: 10.1038/S41391-020-0251-1 |
0.381 |
|
2020 |
Wong CK, Lambert AW, Ozturk S, Papageorgis P, Lopez D, Shen N, Sen Z, Abdolmaleky HM, Győrffy B, Feng H, Thiagalingam S. Targeting RICTOR sensitizes SMAD4-negative colon cancer to irinotecan. Molecular Cancer Research : McR. PMID 31932471 DOI: 10.1158/1541-7786.Mcr-19-0525 |
0.806 |
|
2019 |
Wong CK, Gromisch C, Ozturk S, Papageorgis P, Abdolmaleky HM, Reinhard BM, Thiagalingam A, Thiagalingam S. MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer. Cancer Biology & Therapy. 1-8. PMID 30922194 DOI: 10.1080/15384047.2019.1595285 |
0.777 |
|
2019 |
Kalli M, Mpekris F, Wong CK, Panagi M, Ozturk S, Thiagalingam S, Stylianopoulos T, Papageorgis P. Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis. Frontiers in Oncology. 9: 32. PMID 30805303 DOI: 10.3389/Fonc.2019.00032 |
0.827 |
|
2017 |
Pappas K, Xu J, Zairis S, Resnick-Silverman L, Abate F, Steinbach N, Ozturk S, Saal LH, Su T, Cheung P, Schmidt H, Aaronson SA, Hibshoosh H, Manfredi JJ, Rabadan R, et al. p53 maintains baseline expression of multiple tumor suppressor genes. Molecular Cancer Research : McR. PMID 28483946 DOI: 10.1158/1541-7786.Mcr-17-0089 |
0.409 |
|
2017 |
Mathur D, Stratikopoulos E, Ozturk S, Steinbach N, Pegno S, Schoenfeld S, Yong R, Murty VV, Asara JM, Cantley LC, Parsons R. PTEN Regulates Glutamine Flux to Pyrimidine Synthesis and Sensitivity to Dihydroorotate Dehydrogenase Inhibition. Cancer Discovery. PMID 28255082 DOI: 10.1158/2159-8290.Cd-16-0612 |
0.443 |
|
2017 |
Wolfe AL, Hopkins BD, Riquelme SA, Kitur K, Ozturk S, Kang K, Remark R, Rahman A, Lin C, Merad M, Szabolcs M, Chen S, Prince A, Parsons R. Abstract 334: PTEN-L regulates epithelial growth and macrophage function Cancer Research. 77: 334-334. DOI: 10.1158/1538-7445.Am2017-334 |
0.386 |
|
2016 |
Ozturk S, Papageorgis P, Wong CK, Lambert AW, Abdolmaleky HM, Thiagalingam A, Cohen HT, Thiagalingam S. SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 26739564 DOI: 10.1073/Pnas.1514663113 |
0.823 |
|
2015 |
Lambert AW, Wong CK, Ozturk S, Papageorgis P, Raghunathan R, Alekseyev Y, Gower AC, Reinhard BM, Abdolmaleky HM, Thiagalingam S. Tumor Cell-Derived Periostin Regulates Cytokines That Maintain Breast Cancer Stem Cells. Molecular Cancer Research : McR. PMID 26507575 DOI: 10.1158/1541-7786.Mcr-15-0079 |
0.817 |
|
2015 |
Papageorgis P, Ozturk S, Lambert AW, Neophytou CM, Tzatsos A, Wong CK, Thiagalingam S, Constantinou AI. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis. Breast Cancer Research : Bcr. 17: 98. PMID 26208975 DOI: 10.1186/S13058-015-0607-Y |
0.809 |
|
2015 |
Papageorgis P, Ozturk S, Lambert AW, Neophytou CM, Tzatsos A, Wong CK, Thiagalingam S, Constantinou AI. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis Breast Cancer Research. 17. DOI: 10.1186/s13058-015-0607-y |
0.797 |
|
2014 |
Abdolmaleky HM, Nohesara S, Ghadirivasfi M, Lambert AW, Ahmadkhaniha H, Ozturk S, Wong CK, Shafa R, Mostafavi A, Thiagalingam S. DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia. Schizophrenia Research. 152: 373-80. PMID 24411530 DOI: 10.1016/J.Schres.2013.12.007 |
0.624 |
|
2013 |
Lambert AW, Ozturk S, Papageorgis P, Abdolmaleky H, Thiagalingam S. Abstract 4890: Periostin signaling regulates breast cancer stem cells. Cancer Research. 73: 4890-4890. DOI: 10.1158/1538-7445.Am2013-4890 |
0.785 |
|
2013 |
Lambert A, Ozturk S, Papageorgis P, Abdolmaleky H, Thiagalingam S. Abstract P1-06-13: Periostin controls cytokine production to maintain breast cancer stem cells Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P1-06-13 |
0.784 |
|
2012 |
Lambert AW, Ozturk S, Thiagalingam S. Integrin signaling in mammary epithelial cells and breast cancer. Isrn Oncology. 2012: 493283. PMID 22523705 DOI: 10.5402/2012/493283 |
0.752 |
|
2012 |
Lambert AW, Ozturk S, Thiagalingam S. Abstract 5191: Periostin signaling in breast cancer stem cells Cancer Research. 72: 5191-5191. DOI: 10.1158/1538-7445.Am2012-5191 |
0.757 |
|
2011 |
Abdolmaleky HM, Yaqubi S, Papageorgis P, Lambert AW, Ozturk S, Sivaraman V, Thiagalingam S. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophrenia Research. 129: 183-90. PMID 21550210 DOI: 10.1016/J.Schres.2011.04.007 |
0.721 |
|
2011 |
Papageorgis P, Cheng K, Ozturk S, Gong Y, Lambert AW, Abdolmaleky HM, Zhou JR, Thiagalingam S. Smad4 inactivation promotes malignancy and drug resistance of colon cancer. Cancer Research. 71: 998-1008. PMID 21245094 DOI: 10.1158/0008-5472.Can-09-3269 |
0.786 |
|
2010 |
Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM, Lenburg M, Thiagalingam S. Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Research. 70: 968-78. PMID 20086175 DOI: 10.1158/0008-5472.Can-09-1872 |
0.799 |
|
2010 |
Thiagalingam S, Lambert AW, Ozturk S, Abdolmaleky HM, Papageorgis P. Abstract 187: Epigenetic memory during breast cancer progression is sustained by Smad signaling pathway Cancer Research. 70: 187-187. DOI: 10.1158/1538-7445.Am10-187 |
0.816 |
|
2009 |
Gao F, Ponte JF, Levy M, Papageorgis P, Cook NM, Ozturk S, Lambert AW, Thiagalingam A, Abdolmaleky HM, Sullivan BA, Thiagalingam S. hBub1 negatively regulates p53 mediated early cell death upon mitotic checkpoint activation. Cancer Biology & Therapy. 8: 548-56. PMID 19252416 DOI: 10.4161/Cbt.8.7.7929 |
0.773 |
|
2009 |
Gao F, Ponte JF, Papageorgis P, Levy M, Ozturk S, Lambert AW, Pan H, Chinnappan D, Cheng KH, Thiagalingam A, Abdolmaleky HM, Thiagalingam S. hBub1 deficiency triggers a novel p53 mediated early apoptotic checkpoint pathway in mitotic spindle damaged cells. Cancer Biology & Therapy. 8: 627-35. PMID 19242126 DOI: 10.4161/Cbt.8.7.7928 |
0.725 |
|
Show low-probability matches. |